Sort by:

select Language:

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

K.Dheda, T. Gumbo, G. Maartens, et al., Eds.: The Lancet Respiratory Medicine Commission, (2017)

Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017

Tuberculosis and Non-Communicable Diseases

World Health Organization; Global TB Programme; Hannah Monica Dias Policy, Strategy and Innovations, (2017)

END TB Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas. Accessded December 2017

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al., Eds.: International Journal of Molecular Scienes, (2017)

Int. J. Mol. Sci. 2017, 18, 341, 1 - 10

BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial

M. A. Gasper, A. C. Hesseling, I. Mohar, et al., Eds.: JCI insight, (2017)

Clinical Medicine JCI Insight. 2017;2(7):e91963.

Out of step 2017

Médecins sans Frontières; Stop TB Partnership, (2017)

TB policies in 29 Countries A survey of prevention, testing and treatment policies and practices

Toolkit for developting a national TB research plan

N. Gebreselassie , C. Lienhardt, L. Anderson et al. , Eds.: World Health Organization, (2016)

The End TB Strategie

164 hits